Headlands Research Further Expands its Leading Clinical Research Site Network by Acquiring Peninsula Research Associates
30 juin 2022 09h00 HE
|
Headlands Research
SAN FRANCISCO, June 30, 2022 (GLOBE NEWSWIRE) -- Headlands Research announced today the acquisition of Peninsula Research Associates (PRA) of Rolling Hills, CA, continuing the growth of its leading...
Groundbreaking Headlands Research and Pfizer Partnership to Significantly Improve Diversity in Clinical Trials
19 mai 2022 09h00 HE
|
Headlands Research
SAN FRANCISCO, May 19, 2022 (GLOBE NEWSWIRE) -- Headlands Research, a leading international network of clinical trial sites, announced today a partnership with Pfizer Inc. to launch new research...
Headlands Research CEO Mark Blumling to Speak at Milken Institute Global Conference
14 oct. 2021 09h00 HE
|
Headlands Research
SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that Founder and CEO...
Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease
16 juin 2021 09h00 HE
|
Headlands Research
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen...
Headlands Research Continues its Rapid Expansion with the Acquisition of Summit Research Network and the Launch of its Fourth Horizons Site
13 mai 2021 09h00 HE
|
Headlands Research
SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced its acquisition of...
Headlands Research Accelerates Growth and Diversity Commitment with the Acquisition of Multi-Site Southern California Based Artemis Institute for Clinical Research
17 févr. 2021 09h00 HE
|
Headlands Research
SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired...
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
01 sept. 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
11 août 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
16 juil. 2020 13h28 HE
|
Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program
07 juil. 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of two large central nervous system...